Table 3.

Process Outcomes by the Disease Management Team Among Intervention Patients

Variablea	Time Spent With Patients		Glucose Medication Titrations or Additions		Actions or Contacts With Patients
	Median, min	P	Median, No.	P	Median, No.	P
Age		.70		.95		.41
Older adult ≥65 y (n = 16)	490		4		45
Non–older adult (n = 82)	455		4		44
Race/ethnicity		.96		.23		.59
White (n = 27)	460		5		44
Nonwhite (n = 71)	450		3		47
Sex		.99		.97		.88
Female (n = 57)	460		4		45
Male (n = 41)	460		4		43
Education		.45		.95		.29
<High school (n = 64)	475		4		43
≥High school (n = 34)	447		4		45
Household annual income, $		.03b	3	.91		.01b
<10,000 (n = 41)	500		3		50
≥10,000 (n = 57)	440		4		43
Private insurance		.01b		.07		.005b
No (n = 59)	475		4		50
Yes (n = 39)	420		3		42
Covered by Medicare or Medicaid		.13		.32		.69
No (n = 61)	450		3		47
Yes (n = 37)	470		5		43
Goal A1C level, %c		.65		.3		.91
>7 (n = 67)	460		4		43
≤7 (n = 31)	440		3		49

A1C indicates glycosylated hemoglobin.

^aNumber of patients is 98 due to 12 patients lost to follow-up and 2 deaths experienced during the study.

^bP <.05.

^cSpearman correlation coefficients for baseline A1C levels are r = −0.04 (P = .69) for time spent with patients, r = 0.01 (P = .88) for glucose medication titrations or additions, and r = 0.00 (P >.99) for actions or contacts with patients.